Victrex plc (LON:VCT - Get Free Report) insider Dame Vivienne Cox purchased 2,747 shares of the company's stock in a transaction dated Tuesday, July 8th. The shares were purchased at an average cost of GBX 721 ($9.79) per share, for a total transaction of £19,805.87 ($26,906.49).
Victrex Stock Down 0.5%
LON VCT traded down GBX 3.60 ($0.05) during trading on Friday, hitting GBX 724.40 ($9.84). The company's stock had a trading volume of 171,582 shares, compared to its average volume of 414,972. The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99. The company has a market cap of £631.91 million, a PE ratio of 20.58, a P/E/G ratio of 1.92 and a beta of 0.69. The business's 50 day simple moving average is GBX 795.78 and its 200-day simple moving average is GBX 890.75. Victrex plc has a fifty-two week low of GBX 667.62 ($9.07) and a fifty-two week high of GBX 1,160 ($15.76).
Victrex (LON:VCT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. On average, equities analysts anticipate that Victrex plc will post 73.1078905 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft downgraded Victrex to a "hold" rating and dropped their price objective for the company from GBX 990 ($13.45) to GBX 850 ($11.55) in a research report on Tuesday. JPMorgan Chase & Co. dropped their price objective on Victrex from GBX 940 ($12.77) to GBX 818 ($11.11) and set a "neutral" rating on the stock in a research report on Wednesday.
View Our Latest Stock Report on Victrex
Victrex Company Profile
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
